Pat Brady

Company: Kymera Therapeutics

Job title: Senior Director, Computational Chemistry

Seminars:

Creating an Alternative to the DEL Separation Step to Reduce False Negatives & Improve Stability 3:45 pm

Reducing false negatives by preserving more potential hits during the DEL separation step Enhancing the stability of DNA-tagged compounds, ensuring more reliable identification of active molecules Streamlining the DEL process without the separation step to boost overall screening efficiency, enabling faster and more accurate hit identificationRead more

day: Conf Day 1